Ken Griffin Amphastar Pharmaceuticals, Inc. Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$38.65 - $43.48 $301,470 - $339,144	-7,800 Reduced 63.93%	4,400 $176,000
Q1 2024 May 15, 2024	BUY	$42.85 - $63.45 $154,260 - $228,420	3,600 Added 41.86%	12,200 $535,000
Q4 2023 Feb 14, 2024	BUY	$44.49 - $62.93 $284,736 - $402,752	6,400 Added 290.91%	8,600 $531,000
Q3 2023 Nov 14, 2023	SELL	$45.51 - $65.0 $81,918 - $117,000	-1,800 Reduced 45.0%	2,200 $101,000
Q2 2023 Aug 14, 2023	BUY	$35.77 - $58.38 $28,616 - $46,704	800 Added 25.0%	4,000 $229,000
Q1 2023 May 15, 2023	BUY	$27.99 - $37.92 $47,583 - $64,464	1,700 Added 113.33%	3,200 $120,000
Q4 2022 Feb 14, 2023	BUY	$27.93 - $31.27 $41,895 - $46,905	1,500 New	1,500 $42,000

285

35.2M

25.5K

24.8K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $2.23B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.